Lipocine Inc.
ORAL TESTOSTERONE TRIDECANOATE THERAPY

Last updated:

Abstract:

The present disclosure provides methods and compositions for testosterone replacement therapy. The methods and compositions employ a fixed dose dosing regimen that does not require titration or dose adjustments and that can provide a therapeutically effective amount of a testosterone ester while avoiding unacceptably high testosterone levels.

Status:
Application
Type:

Utility

Filling date:

26 Dec 2019

Issue date:

16 Jul 2020